Nluc Reporter Cell Line - CMT93

The CMT93 cell line is a mouse rectal cancer cell line that has been widely used in biomedical research, particularly in the fields of cancer biology, immunology, and cell signaling pathways. Derived from a spontaneous rectal tumor in a mouse, this epithelial cell line exhibits adherent growth characteristics and retains the features of cancer cells, making it a valuable model for studying tumor development, metastasis, and therapeutic interventions. Researchers favor the CMT93 cell line due to its good stability, reproducibility, and relevance to colorectal cancer research, allowing for in-depth understanding of molecular mechanisms such as cell proliferation, apoptosis, and immune evasion.

The Nluc reporter cell line - CMT93 is a genetically engineered derivative of the parental CMT93 cells, incorporating the NanoLuc (Nluc) luciferase reporter gene. This modification enables highly sensitive bioluminescent detection, revolutionizing quantitative analysis methods for real-time monitoring of cellular processes. The applications of this reporter gene cell line span multiple fields, including high-throughput drug screening, where it allows for rapid assessment of compound efficacy and toxicity by measuring luminescence signals associated with cell viability or specific pathway activation. In immunology, it serves as a tool for studying the interaction between immune cells and tumor cells, such as in cytotoxicity assays involving T cells or natural killer cells. Furthermore, the Nluc reporter gene cell line - CMT93 supports gene expression studies using promoter-reporter constructs, enabling researchers to track changes in transcriptional activity induced by stimuli such as cytokines or pathogens.